Silverback Therapeutics, Inc. (51) | Business Operations (4)

Browse by Subcategory

Collaboration Agreements (2 contracts)
Services Agreements (2)

Recent Contracts

Collaboration and License Agreement, dated as of April 30, 2020, by and between ARS Pharmaceuticals, Inc. and Alfresa Pharma Corporation (Filed With SEC on November 8, 2022)
Master Laboratory Services Agreement, by and between the registrant and Q Squared Solutions LLC, dated May 25, 2020 (Filed With SEC on November 10, 2020)
Collaboration and Distribution Agreement, dated as of March 1, 2021, by and between ARS Pharmaceuticals, Inc. and Pediatrix Therapeutics (Filed With SEC on November 8, 2022)
Master Services Agreement, by and between the registrant and CE3, Inc., dated January 21, 2020 (Filed With SEC on November 10, 2020)